adamantane and Burns
adamantane has been researched along with Burns in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Huang, X; Liu, H; Liu, Q; Shu, Y; Yang, Y; Ye, H; Yu, B; Zhan, A | 1 |
| Cameron, MD; Deng, Y; Dong, LB; Duan, Y; Feng, X; Huang, Y; Qiu, L; Rudolf, JD; Ruiz, CH; Shen, B; Su, M | 1 |
| Ferrara, JJ; Flint, LM; Force, SD; Franklin, EW; Hyman, AL; Lippton, HL; Taheri, PA | 1 |
Other Studies
3 other study(ies) available for adamantane and Burns
| Article | Year |
|---|---|
A designed supramolecular cross-linking hydrogel for the direct, convenient, and efficient administration of hydrophobic drugs.
Topics: 3T3 Cells; Adamantane; Animals; Anti-Inflammatory Agents; beta-Cyclodextrins; Burns; Cell Survival; Cross-Linking Reagents; Dexamethasone; Drug Delivery Systems; Drug Liberation; Hyaluronic Acid; Hydrogels; Hydrophobic and Hydrophilic Interactions; Mice; Polyethylene Glycols; Rats, Sprague-Dawley; Wound Healing | 2020 |
Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models.
Topics: Adamantane; Aminobenzoates; Anilides; Animals; Anti-Bacterial Agents; Biofilms; Burns; Disease Models, Animal; Drug Resistance, Bacterial; Drug Stability; Fatty Acid Synthase, Type II; Fatty Acid Synthesis Inhibitors; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microsomes; Peritonitis; Prodrugs; Staphylococcal Skin Infections; Sulfides; Treatment Outcome | 2019 |
Analysis of regional hemodynamic regulation in response to scald injury.
Topics: Adamantane; Animals; Arginine; Atropine; Blood Pressure; Burns; Diphenhydramine; Dogs; Femoral Artery; Hemodynamics; Hindlimb; Histamine; Isoproterenol; Meclofenamic Acid; Methoxamine; Methysergide; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroglycerin; Pulmonary Circulation; Ranitidine; Regional Blood Flow; Ritanserin; Serotonin; Serotonin Receptor Agonists; Time Factors; Triazines; Ultrasonography; Vascular Resistance; Vasodilation; Verapamil; Xanthines | 1994 |